Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The helminth mitochondrial respiratory chain is a specialized metabolic system essential for the survival of parasitic flatworms, including tapeworms (cestodes). Unlike their mammalian hosts, many adult helminths inhabit anaerobic or microaerobic environments within the host's gastrointestinal tract and rely on a unique anaerobic respiratory pathway known as the NADH-fumarate reductase system (Kita et al., 2012). This system utilizes rhodoquinone as an electron carrier to reduce fumarate to succinate, a process catalyzed by a parasite-specific complex II (fumarate reductase) that differs significantly from the succinate dehydrogenase found in humans (Omura et al., 2001). Drugs such as niclosamide target this machinery by acting as uncouplers of oxidative phosphorylation, which dissipates the mitochondrial proton gradient and halts ATP production (Winn et al., 2021). Other anthelmintics, like certain benzimidazoles and specialized inhibitors like nafuredin, directly interfere with the enzymes of this respiratory chain (Kita et al., 2012). Because of these distinct biochemical adaptations, the tapeworm mitochondrial machinery represents a highly effective target for selective chemotherapy against helminthic infections. Disruption of this machinery leads to rapid ATP depletion, loss of motor function, and eventual death of the parasite.
Uncoupling of oxidative phosphorylation and inhibition of the NADH-fumarate reductase system, leading to the dissipation of the mitochondrial membrane potential and depletion of cellular ATP (Kita et al., 2012; Winn et al., 2021).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helminth mitochondrial respiratory chain.